tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Verastem Unveils Promising VS-7375 Study Results
PremiumCompany AnnouncementsVerastem Unveils Promising VS-7375 Study Results
26d ago
Verastem’s VS-7375 shows efficacy in lung cancer
Premium
The Fly
Verastem’s VS-7375 shows efficacy in lung cancer
26d ago
Verastem Inc. Earnings Call: Positive Outlook with Key Achievements
Premium
Company Announcements
Verastem Inc. Earnings Call: Positive Outlook with Key Achievements
26d ago
Verastem reports Q2 EPS (39c) vs. (31c) last year
PremiumThe FlyVerastem reports Q2 EPS (39c) vs. (31c) last year
1M ago
VSTM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VSTM Earnings this Week: How Will it Perform?
1M ago
Verastem’s Phase 3 Study: A New Hope for Ovarian Cancer Treatment
Premium
Company Announcements
Verastem’s Phase 3 Study: A New Hope for Ovarian Cancer Treatment
1M ago
Verastem’s Promising Phase 3 Study on Recurrent Ovarian Cancer
PremiumCompany AnnouncementsVerastem’s Promising Phase 3 Study on Recurrent Ovarian Cancer
2M ago
Verastem announces Nature Medicine publication of FRAME results
Premium
The Fly
Verastem announces Nature Medicine publication of FRAME results
2M ago
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
Premium
Company Announcements
Verastem’s Promising Phase 3 Study on Avutometinib and Defactinib in Ovarian Cancer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100